Compounds > bisbenzimidazole
Page last updated: 2024-10-23

bisbenzimidazole and Chromosomal Fragility

bisbenzimidazole has been researched along with Chromosomal Fragility in 2 studies

Bisbenzimidazole: A benzimidazole antifilarial agent; it is fluorescent when it binds to certain nucleotides in DNA, thus providing a tool for the study of DNA replication; it also interferes with mitosis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacky, PB2
Dill, FJ1
Sutherland, GR1
Baker, EG1

Other Studies

2 other studies available for bisbenzimidazole and Chromosomal Fragility

ArticleYear
Fragile X chromosome and chromosome condensation.
    Annales de genetique, 1983, Volume: 26, Issue:3

    Topics: Aged; Bisbenzimidazole; Chromosome Fragile Sites; Chromosome Fragility; Dactinomycin; Ethidium; Fema

1983
Heritable fragile sites on human chromosomes. XI. Factors affecting expression of fragile sites at 10q25, 16q22, and 17p12.
    American journal of human genetics, 1984, Volume: 36, Issue:1

    Topics: Bisbenzimidazole; Bromodeoxycytidine; Bromodeoxyuridine; Cells, Cultured; Chromosome Fragile Sites;

1984